CAM

Cormorant Asset Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 314.52%
This Quarter Est. Return
1 Year Est. Return
+314.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$107M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$173M
2
+$10.3M
3
+$9.19M
4
RAPP
Rapport Therapeutics
RAPP
+$7.47M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$6.79M

Top Sells

1
+$58.9M
2
+$46.6M
3
+$33.1M
4
VRNA
Verona Pharma
VRNA
+$33.1M
5
SPRY icon
ARS Pharmaceuticals
SPRY
+$19.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNA icon
26
Avidity Biosciences
RNA
$10.8B
$13.1M 0.9%
300,000
+100,000
BIOA
27
BioAge Labs
BIOA
$340M
$12.6M 0.87%
2,140,605
AXSM icon
28
Axsome Therapeutics
AXSM
$7.64B
$12.1M 0.84%
100,000
CABA icon
29
Cabaletta Bio
CABA
$247M
$11.7M 0.81%
5,000,000
ORKA
30
Oruka Therapeutics
ORKA
$1.46B
$10.3M 0.71%
+533,340
ALMS
31
Alumis Inc
ALMS
$801M
$8.57M 0.59%
2,147,396
BMEA icon
32
Biomea Fusion
BMEA
$77.1M
$7.21M 0.5%
3,570,872
AMLX icon
33
Amylyx Pharmaceuticals
AMLX
$1.65B
$6.79M 0.47%
+500,000
PCVX icon
34
Vaxcyte
PCVX
$6.49B
$6.3M 0.43%
175,000
ELVN icon
35
Enliven Therapeutics
ELVN
$1.28B
$4.09M 0.28%
200,000
BHVN icon
36
Biohaven
BHVN
$1.33B
$150K 0.01%
10,000
CRGX
37
DELISTED
CARGO Therapeutics
CRGX
– –
-3,381,277
KALA icon
38
KALA BIO
KALA
$7.93M
– –
-603,027
MRUS icon
39
Merus
MRUS
$7.29B
– –
-1,120,000
SPRY icon
40
ARS Pharmaceuticals
SPRY
$943M
– –
-1,100,000
STOK icon
41
Stoke Therapeutics
STOK
$1.77B
– –
-254,161
VRNA
42
DELISTED
Verona Pharma
VRNA
– –
-350,000
VYNE icon
43
VYNE Therapeutics
VYNE
$12.8M
– –
-1,370,938
AARD
44
Aardvark Therapeutics
AARD
$217M
– –
-800,189
1
2